Efficacy of anti-PD-1 therapy in a patient with brain metastasis of parotid carcinoma: A case report

CheckMate 141, an open-label, randomized phase III trial of nivolumab, indicated that treatment with nivolumab prolonged overall survival of patients with platinum-refractory, recurrent head and neck squamous cell carcinoma. Herein, we describe a case of brain metastasis of parotid carcinoma in whic...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Auris, nasus, larynx nasus, larynx, 2019-10, Vol.46 (5), p.813-817
Hauptverfasser:	Takemoto, Kota, Miyahara, Nobuyuki, Chikuie, Nobuyuki, Hamamoto, Takao, Ishino, Takashi, Ueda, Tsutomu, Takeno, Sachio
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antineoplastic Agents, Immunological - therapeutic use Antineoplastic Combined Chemotherapy Protocols - therapeutic use Brain metastasis Brain Neoplasms - drug therapy Brain Neoplasms - secondary Cetuximab - administration & dosage Chemoradiotherapy Cisplatin - administration & dosage Female Fluorouracil - administration & dosage Head and neck Humans Immune checkpoint inhibitor Induction Chemotherapy Lung Neoplasms - drug therapy Lung Neoplasms - secondary Neoplasm, Residual Nivolumab - therapeutic use Parotid Neoplasms - diagnostic imaging Parotid Neoplasms - pathology Parotid Neoplasms - therapy Squamous cell carcinoma Squamous Cell Carcinoma of Head and Neck - diagnostic imaging Squamous Cell Carcinoma of Head and Neck - secondary Squamous Cell Carcinoma of Head and Neck - therapy Treatment Failure Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!